Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
316.63
-0.77 (-0.24%)
At close: Jun 26, 2026, 4:00 PM EDT
316.63
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:00 PM EDT

Company Description

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands.

In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products.

Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum.

It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Penumbra, Inc.
Penumbra logo
Country United States
Founded 2004
IPO Date Sep 18, 2015
Industry Medical Devices
Sector Healthcare
Employees 4,700
CEO Adam Elsesser

Contact Details

Address:
One Penumbra Place
Alameda, California 94502
United States
Phone 510 748 3200
Website penumbrainc.com

Stock Details

Ticker Symbol PEN
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001321732
CUSIP Number 70975L107
ISIN Number US70975L1070
SIC Code 3841

Key Executives

Name Position
Adam Elsesser J.D. Co-Founder, Chairman and Chief Executive Officer
Shruthi Narayan President
Dr. Arani Bose M.D. Co-Founder and Director
Maggie S. Yuen Chief Financial Officer
Lambert Shiu Chief Accounting Officer
Johanna Roberts J.D. Executive Vice President, General Counsel and Secretary
Ben Sorci Executive Vice President of Operations
Pankaj Tiwari Executive Vice President and Chief Information Officer
Jee Hamlyn-Harris Investor Relations Officer
Ben Tompkins Executive Vice President of Development and Compliance

Latest SEC Filings

Date Type Title
Jun 22, 2026 8-K Current Report
May 29, 2026 SD Form - SD
May 7, 2026 425 Filing
May 7, 2026 8-K Current Report
May 6, 2026 10-Q Quarterly Report
May 6, 2026 8-K Current Report
Apr 30, 2026 SCHEDULE 13G Filing
Apr 29, 2026 ARS Filing
Apr 29, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2026 DEF 14A Other definitive proxy statements